Lv7
5000 积分 2021-07-15 加入
Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study
22天前
已完结
Up‐front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra‐nodal NKT cell lymphoma: A multicenter real‐world study in China
22天前
已完结
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
22天前
已完结
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
22天前
已完结
Pemigatinib for Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
1个月前
已完结
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
1个月前
已完结
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial
1个月前
已完结
Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs
4个月前
已完结
A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition
4个月前
已完结
Identification of potential biomarkers for the study of the mechanisms of immune thrombocytopenia using bioinformatics and metabolomics
4个月前
已完结
皖公网安备34019202002308
